What to watch with FADS1 and Allergie?

FADS1 encodes a key enzyme in the biosynthesis of long-chain polyunsaturated fatty acids. Variants like rs174546 are linked to altered levels of arachidonic acid and EPA/DHA, which modulate inflammatory pathways relevant to allergies. Evidence comes mainly from GWAS and mechanistic studies; clinical utility for allergy management remains limited. Consumer DNA tests can indicate a genetic tendency but do not diagnose allergies. Practical steps include ensuring adequate omega-3 intake (e.g., fatty fish, algae oil) and monitoring personal tolerance. A blood test for fatty acid profiles or inflammatory markers (e.g., hs-CRP) provides more actionable data. Be cautious of overinterpretation: while FADS1 influences omega-3/6 balance, its effect on allergic outcomes is modest and context-dependent (diet, microbiome, environment). No strong clinical guidelines exist yet.